Less inflammation?
Read the endpoint.
The useful takeaway
Changes in blood markers can be scientifically interesting without proving that people will feel better or avoid disease.
What the paper examined
A 2026 network meta-analysis compared 14 supplement strategies across 60 randomized trials in adults with overweight or obesity. The outcomes were inflammatory biomarkers.
What it found
The abstract reports lower CRP and TNF-α with probiotics combined with omega-3. Effects differed across the biomarkers and supplement strategies examined.
What it means—and what it doesn’t
The combination finding cannot isolate the contribution of omega-3 alone. Biomarker changes do not establish prevention of heart attacks, improvements in symptoms, or benefits from a specific commercial product. Network rankings also should not be read as a universal shopping list.
What to check next
The authors highlight differences in doses, duration, and participant characteristics. A full appraisal should examine the underlying comparisons, certainty, and study limitations. This summary is based on the abstract; it is not a treatment recommendation.
Back to the research journal ↗